LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Nov 2, 2024 | (Q2)Aug 3, 2024 | (Q1)May 4, 2024 | (FY)Feb 3, 2024 | (Q4)Feb 3, 2024 | (Q3)Oct 28, 2023 | (Q2)Jul 29, 2023 | (Q1)Apr 29, 2023 | (FY)Jan 28, 2023 | (Q4)Jan 28, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -544.74%-22.61M | -94.35%1.4M | -66.18%-14.55M | 457.60%47.99M | 15.42%26.94M | 152.73%5.08M | 254.22%24.73M | 21.00%-8.76M | -133.67%-13.42M | 13.01%23.34M |
Net income from continuing operations | -350.10%-12.8M | -38.34%5.71M | -73.56%-8.12M | 109.87%7.84M | 95.43%-1.86M | 5.98%5.12M | 125.08%9.25M | 30.27%-4.68M | -492.64%-79.38M | -818.24%-40.6M |
Depreciation and amortization | 1.45%7.88M | -9.03%7.16M | -9.85%7.35M | -5.33%31.91M | -5.27%8.11M | -9.80%7.77M | -5.24%7.87M | -0.79%8.16M | 2.40%33.7M | -2.82%8.56M |
Deferred tax | -118.23%-192K | -130.98%-333K | -60.18%409K | 109.96%1.76M | 88.54%-1.39M | 1,102.86%1.05M | 120.30%1.08M | 934.96%1.03M | -5,308.26%-17.69M | -2,887.96%-12.16M |
Other non cash items | -270.00%-17K | -92.86%1K | -46.15%14K | 16.67%7K | ---43K | --10K | --14K | --26K | 116.22%6K | ---- |
Change In working capital | -111.88%-20.55M | -308.18%-11.71M | -7.31%-15.04M | 90.72%-2.21M | -41.12%15.88M | 59.86%-9.7M | 142.71%5.63M | -4.10%-14.01M | -32.25%-23.83M | 349.43%26.97M |
-Change in receivables | 150.03%863K | -96.99%-7.25M | -143.37%-792K | 446.77%4.67M | 174.43%8.25M | -492.94%-1.73M | 33.08%-3.68M | 157.55%1.83M | -119.92%-1.35M | -67.73%3.01M |
-Change in inventory | -82.94%1.73M | -328.63%-7.87M | -1,377.94%-6.9M | 820.84%24M | -69.88%10.86M | 730.83%10.16M | 119.36%3.44M | 97.24%-467K | 175.21%2.61M | 965.57%36.06M |
-Change in prepaid assets | 278.61%3.21M | -301.08%-2.42M | -3,225.51%-3.26M | -121.46%-833K | -112.97%-145K | -174.30%-1.8M | 6.26%1.21M | 87.53%-98K | 75.26%3.88M | 189.58%1.12M |
-Change in payables and accrued expense | -101.11%-22.61M | 64.58%13.7M | 175.99%5.69M | 34.08%-8.05M | 123.70%2.36M | 51.13%-11.24M | -49.81%8.33M | -279.96%-7.49M | -355.87%-12.21M | -711.06%-9.95M |
-Change in other current liabilities | -5.43%-6.27M | 5.58%-5.47M | -20.43%-5.74M | 9.72%-22.93M | -4.86%-6.43M | 6.44%-5.94M | 8.76%-5.79M | 27.45%-4.76M | 2.17%-25.4M | 8.25%-6.14M |
-Change in other working capital | 198.46%2.53M | -213.04%-2.4M | -33.60%-4.04M | -89.21%932K | -65.63%985K | -24.46%846K | 266.93%2.13M | -151.04%-3.02M | 469.15%8.64M | 825.57%2.87M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -544.74%-22.61M | -94.35%1.4M | -66.18%-14.55M | 457.60%47.99M | 15.42%26.94M | 152.73%5.08M | 254.22%24.73M | 21.00%-8.76M | -133.67%-13.42M | 13.01%23.34M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -193.16%-2.4M | -206.49%-2.79M | 92.02%-863K | -67.13%-13.77M | 3.70%-1.22M | 68.22%-819K | 65.65%-909K | -519.94%-10.82M | -98.34%-8.24M | -29.56%-1.27M |
Net PPE purchase and sale | -193.16%-2.4M | -206.49%-2.79M | -5.50%-863K | 54.24%-3.77M | 3.70%-1.22M | 68.22%-819K | 65.65%-909K | 53.12%-818K | -51.34%-8.24M | 12.71%-1.27M |
Net business purchase and sale | --0 | --0 | --0 | ---10M | --0 | --0 | --0 | ---10M | --0 | --0 |
Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -193.16%-2.4M | -206.49%-2.79M | 92.02%-863K | -67.13%-13.77M | 3.70%-1.22M | 68.22%-819K | 65.65%-909K | -519.94%-10.82M | -98.34%-8.24M | -29.56%-1.27M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -970.87%-5.52M | -1,313.18%-9.65M | -300.48%-6.7M | 82.35%-3.55M | 13.78%-676K | 37.27%-515K | 90.11%-683K | 85.56%-1.67M | -76.16%-20.11M | 86.93%-784K |
Net common stock issuance | -989.90%-5.29M | -1,297.51%-9.55M | -767.21%-6.35M | 87.86%-2.19M | 62.76%-292K | 39.45%-485K | 89.40%-683K | 92.71%-732K | -133.30%-18.06M | 86.35%-784K |
Net other financing activities | -663.33%-229K | ---107K | 62.21%-356K | 33.63%-1.36M | ---384K | -50.00%-30K | --0 | 39.46%-942K | 44.35%-2.04M | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -970.87%-5.52M | -1,313.18%-9.65M | -300.48%-6.7M | 82.35%-3.55M | 13.78%-676K | 37.27%-515K | 90.11%-683K | 85.56%-1.67M | -76.16%-20.11M | 86.93%-784K |
Net cash flow | ||||||||||
Beginning cash position | -9.02%44.15M | 117.83%55.2M | 65.90%77.3M | -47.31%46.6M | 107.10%52.27M | 26.62%48.52M | -60.40%25.34M | -47.31%46.6M | 37.80%88.44M | -66.25%25.24M |
Current changes in cash | -914.14%-30.52M | -147.71%-11.04M | -4.09%-22.12M | 173.45%30.68M | 17.63%25.04M | 128.75%3.75M | 190.41%23.14M | 12.99%-21.25M | -271.91%-41.77M | 55.67%21.28M |
Effect of exchange rate changes | 1,820.00%86K | -117.39%-8K | 180.00%8K | 143.42%33K | -97.37%2K | 89.13%-5K | 161.33%46K | 67.74%-10K | -130.30%-76K | 500.00%76K |
End cash Position | -73.77%13.71M | -9.02%44.15M | 117.83%55.2M | 65.90%77.3M | 65.90%77.3M | 107.10%52.27M | 26.62%48.52M | -60.40%25.34M | -47.31%46.6M | -47.31%46.6M |
Free cash flow | -686.47%-25.01M | -105.83%-1.39M | -60.99%-15.41M | 304.17%44.22M | 16.52%25.71M | 134.90%4.26M | 227.51%23.82M | 25.37%-9.57M | -163.02%-21.66M | 14.96%22.07M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |